Chimera Investment (CIM) Tops Q1 EPS by 6c

Chimera Investment (NYSE: CIM) reported Q1 EPS of $0.36, $0.06 better than the analyst estimate of $0.30.

For earnings history and earnings-related data on Chimera Investment (CIM) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Legence Corp. (LGN) Misses Q2 EPS by 58c
• Ascendis Pharma (ASND) Tops Q2 EPS by 132c